Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.3.2 is now shown in the Record History, replacing the previous v3.3.1 entry.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page history shows a new site revision v3.3.1 added and v3.2.0 removed. This is a minor system update that does not change core study data or trial content.SummaryDifference0.1%

- Check16 days agoChange DetectedRemoved the site-wide government funding status notice from the page, which does not affect the study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check30 days agoChange DetectedThe new screenshot shows only minor visual/UI refinements of the Record History page with no changes to listed versions or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded a government-funding notice and updated the version to v3.2.0; removed the prior v3.1.0 tag.SummaryDifference10%

- Check66 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.2%

Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.